Health-related quality of life (QoL) in randomized phase III trials in oncology: Association between results of QoL, results of primary endpoint and drug approval.

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Clinical Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Economics And Econometrics

Randomized Controlled Trial

Show all topics

DOI

10.1200/jco.2024.42.16_suppl.11109